Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: meta-analyses of randomized, controlled trials and implications for the future.

MLA

Di Martino, Vincent, et al. “Response-Guided Peg-Interferon plus Ribavirin Treatment Duration in Chronic Hepatitis C: Meta-Analyses of Randomized, Controlled Trials and Implications for the Future.” Hepatology (Baltimore, Md.), vol. 54, no. 3, Sept. 2011, pp. 789–800. EBSCOhost, https://doi.org/10.1002/hep.24480.

APA

Di Martino, V., Richou, C., Cervoni, J.-P., Sanchez-Tapias, J. M., Jensen, D. M., Mangia, A., Buti, M., Sheppard, F., Ferenci, P., & Thévenot, T. (2011). Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: meta-analyses of randomized, controlled trials and implications for the future. Hepatology (Baltimore, Md.), 54(3), 789–800. https://doi.org/10.1002/hep.24480

Chicago

Di Martino, Vincent, Carine Richou, Jean-Paul Cervoni, Jose M Sanchez-Tapias, Donald M Jensen, Alessandra Mangia, Maria Buti, Frances Sheppard, Peter Ferenci, and Thierry Thévenot. 2011. “Response-Guided Peg-Interferon plus Ribavirin Treatment Duration in Chronic Hepatitis C: Meta-Analyses of Randomized, Controlled Trials and Implications for the Future.” Hepatology (Baltimore, Md.) 54 (3): 789–800. doi:10.1002/hep.24480.